Entry |
|
Symbol |
MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK
|
Name |
(RefSeq) mitogen-activated protein kinase 3
|
KO |
|
Organism |
|
Pathway |
hsa01521 | EGFR tyrosine kinase inhibitor resistance |
hsa04072 | Phospholipase D signaling pathway |
hsa04261 | Adrenergic signaling in cardiomyocytes |
hsa04270 | Vascular smooth muscle contraction |
hsa04550 | Signaling pathways regulating pluripotency of stem cells |
hsa04613 | Neutrophil extracellular trap formation |
hsa04620 | Toll-like receptor signaling pathway |
hsa04621 | NOD-like receptor signaling pathway |
hsa04625 | C-type lectin receptor signaling pathway |
hsa04650 | Natural killer cell mediated cytotoxicity |
hsa04658 | Th1 and Th2 cell differentiation |
hsa04660 | T cell receptor signaling pathway |
hsa04662 | B cell receptor signaling pathway |
hsa04664 | Fc epsilon RI signaling pathway |
hsa04666 | Fc gamma R-mediated phagocytosis |
hsa04723 | Retrograde endocannabinoid signaling |
hsa04810 | Regulation of actin cytoskeleton |
hsa04914 | Progesterone-mediated oocyte maturation |
hsa04919 | Thyroid hormone signaling pathway |
hsa04928 | Parathyroid hormone synthesis, secretion and action |
hsa04933 | AGE-RAGE signaling pathway in diabetic complications |
hsa04935 | Growth hormone synthesis, secretion and action |
hsa04960 | Aldosterone-regulated sodium reabsorption |
hsa05022 | Pathways of neurodegeneration - multiple diseases |
hsa05130 | Pathogenic Escherichia coli infection |
hsa05163 | Human cytomegalovirus infection |
hsa05166 | Human T-cell leukemia virus 1 infection |
hsa05167 | Kaposi sarcoma-associated herpesvirus infection |
hsa05170 | Human immunodeficiency virus 1 infection |
hsa05207 | Chemical carcinogenesis - receptor activation |
hsa05208 | Chemical carcinogenesis - reactive oxygen species |
hsa05230 | Central carbon metabolism in cancer |
hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
|
Network |
|
Element |
N00001 | EGF-EGFR-RAS-ERK signaling pathway |
N00002 | BCR-ABL fusion kinase to RAS-ERK signaling pathway |
N00003 | Mutation-activated KIT to RAS-ERK signaling pathway |
N00004 | Duplication or mutation-activated FLT3 to RAS-ERK signaling pathway |
N00005 | Mutation-activated MET to RAS-ERK signaling pathway |
N00006 | Amplified EGFR to RAS-ERK signaling pathway |
N00007 | EML4-ALK fusion kinase to RAS-ERK signaling pathway |
N00008 | RET fusion kinase to RAS-ERK signaling pathway |
N00009 | TRK fusion kinase to RAS-ERK signaling pathway |
N00011 | Mutation-activated FGFR3 to RAS-ERK signaling pathway |
N00012 | Mutation-activated KRAS/NRAS to ERK signaling pathway |
N00013 | Mutation-activated BRAF to ERK signaling pathway |
N00014 | Mutation-activated EGFR to RAS-ERK signaling pathway |
N00015 | PDGF-PDGFR-RAS-ERK signaling pathway |
N00016 | PDGF-overexpression to RAS-ERK signaling pathway |
N00018 | Amplified PDGFR to RAS-ERK signaling pathway |
N00019 | FGF-FGFR-RAS-ERK signaling pathway |
N00020 | Amplified FGFR to RAS-ERK signaling pathway |
N00021 | EGF-ERBB2-RAS-ERK signaling pathway |
N00022 | ERBB2-overexpression to RAS-ERK signaling pathway |
N00023 | EGF-EGFR-PLCG-ERK signaling pathway |
N00024 | Mutation-activated EGFR to PLCG-ERK signaling pathway |
N00025 | EML4-ALK fusion kinase to PLCG-ERK signaling pathway |
N00041 | EGFR-overexpression to RAS-ERK signaling pathway |
N00077 | HRAS-overexpression to ERK signaling pathway |
N00078 | Mutation-activated HRAS to ERK signaling pathway |
N00152 | CXCR-GNB/G-ERK signaling pathway |
N00215 | KITLG-KIT-RAS-ERK signaling pathway |
N00216 | HGF-MET-RAS-ERK signaling pathway |
N00217 | FLT3LG-FLT3-RAS-ERK signaling pathway |
N00229 | TGFA-EGFR-RAS-ERK signaling pathway |
N00230 | TGFA-overexpression to RAS-ERK signaling pathway |
N00233 | IGF-IGF1R-RAS-ERK signaling pathway |
N00235 | IGF2-overexpression to RAS-ERK signaling pathway |
N00237 | IGF1R-overexpression to RAS-ERK signaling pathway |
N00246 | HGF-overexpression to RAS-ERK signaling pathway |
N00248 | MET-overexpression to RAS-ERK signaling pathway |
N00252 | Amplified ERBB2 to RAS-ERK signaling pathway |
N00259 | Amplified MET to RAS-ERK signaling pathway |
N00276 | EGF-overexpression to RAS-ERK signaling pathway |
N00277 | EREG-EGFR-RAS-ERK signaling pathway |
N00278 | EREG-overexpression to RAS-ERK signaling pathway |
N00279 | AREG-EGFR-RAS-ERK signaling pathway |
N00280 | AREG-overexpression to RAS-ERK signaling pathway |
N00318 | EGFR-ERK-ACTH signaling pathway |
N00319 | Mutation-activated USP8 to EGFR-ERK-ACTH signaling pathway |
N00367 | HPV E5 to EGFR-RAS-ERK signaling pathway |
N00386 | HCMV gB to PDGFR-RAS-ERK signaling pathway |
N00438 | TLR2/4-MAPK signaling pathway |
N00439 | HIV Nef to TLR2/4-MAPK signaling pathway |
N00513 | Mutation-activated EGFR to RAS-ERK signaling pathway |
N00518 | HCV Core to ERK signaling pathway |
N00538 | Ca2+-PYK2-RAS-ERK signaling pathway |
N00540 | HBV HBx to RAS-ERK signaling pathway |
N00545 | HBV HBx to ERK signaling pathway |
N00546 | CXCL12-CXCR4-PKC-ERK signaling pathaway |
N00873 | GnRH-GnRHR-PLCB-PKC signaling pathway |
N00879 | PROK-PRKR-Gi-ERK signaling pathway |
N00994 | AGE-RAGE signaling pathway |
N00996 | Mutation-caused aberrant Abeta to AGE-RAGE signaling pathway |
N01062 | Mutation-activated MET to RAS-ERK signaling pathway |
N01064 | Mutation-activated RET to RAS-ERK signaling pathway |
N01119 | RAC/CDC42-PAK-ERK signaling pathway |
N01121 | Salmonella SpvC to ERK signaling pathway |
N01204 | PRNP-PI3K-NOX2 signaling pathway |
N01283 | Shigella OspF to TLR2/4-MAPK signaling pathway |
N01343 | ACH-CHRN-RAS-ERK signaling pathway |
N01344 | NNK/NNN to RAS-ERK signaling pathway |
N01351 | E2-ER-RAS-ERK signaling pathway |
N01352 | BPA to RAS-ERK signaling pathway |
N01353 | E2 to RAS-ERK signaling pathway |
N01354 | BPA to RAS-ERK signaling pathway |
N01360 | P4-PR-RAS-ERK signaling pathway |
N01361 | P4/MPA to PR-RAS-ERK signaling pathway |
N01408 | Metals to RAS-ERK signaling pathway |
N01592 | GF-RTK-RAS-ERK signaling pathway |
N01593 | Regulation of GF-RTK-RAS-ERK signaling, PTP |
N01602 | ERK-MYC signaling pathway |
N01751 | Macrophage EPO signaling |
N01774 | ERK-DUSP4 negative feedback pathway |
N01775 | Inactivation of CaMKII by inducing SERCA2 |
N01823 | FGF23-NCC/NPT signaling pathway |
|
Drug target |
|
Brite |
KEGG Orthology (KO) [BR:hsa00001]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
5595 (MAPK3)
04012 ErbB signaling pathway
5595 (MAPK3)
04014 Ras signaling pathway
5595 (MAPK3)
04015 Rap1 signaling pathway
5595 (MAPK3)
04350 TGF-beta signaling pathway
5595 (MAPK3)
04370 VEGF signaling pathway
5595 (MAPK3)
04371 Apelin signaling pathway
5595 (MAPK3)
04668 TNF signaling pathway
5595 (MAPK3)
04066 HIF-1 signaling pathway
5595 (MAPK3)
04068 FoxO signaling pathway
5595 (MAPK3)
04072 Phospholipase D signaling pathway
5595 (MAPK3)
04071 Sphingolipid signaling pathway
5595 (MAPK3)
04024 cAMP signaling pathway
5595 (MAPK3)
04022 cGMP-PKG signaling pathway
5595 (MAPK3)
04151 PI3K-Akt signaling pathway
5595 (MAPK3)
04150 mTOR signaling pathway
5595 (MAPK3)
09140 Cellular Processes
09141 Transport and catabolism
04140 Autophagy - animal
5595 (MAPK3)
04148 Efferocytosis
5595 (MAPK3)
09143 Cell growth and death
04114 Oocyte meiosis
5595 (MAPK3)
04210 Apoptosis
5595 (MAPK3)
04218 Cellular senescence
5595 (MAPK3)
09144 Cellular community - eukaryotes
04510 Focal adhesion
5595 (MAPK3)
04520 Adherens junction
5595 (MAPK3)
04540 Gap junction
5595 (MAPK3)
04550 Signaling pathways regulating pluripotency of stem cells
5595 (MAPK3)
09142 Cell motility
04810 Regulation of actin cytoskeleton
5595 (MAPK3)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
5595 (MAPK3)
04613 Neutrophil extracellular trap formation
5595 (MAPK3)
04620 Toll-like receptor signaling pathway
5595 (MAPK3)
04621 NOD-like receptor signaling pathway
5595 (MAPK3)
04625 C-type lectin receptor signaling pathway
5595 (MAPK3)
04650 Natural killer cell mediated cytotoxicity
5595 (MAPK3)
04660 T cell receptor signaling pathway
5595 (MAPK3)
04658 Th1 and Th2 cell differentiation
5595 (MAPK3)
04659 Th17 cell differentiation
5595 (MAPK3)
04657 IL-17 signaling pathway
5595 (MAPK3)
04662 B cell receptor signaling pathway
5595 (MAPK3)
04664 Fc epsilon RI signaling pathway
5595 (MAPK3)
04666 Fc gamma R-mediated phagocytosis
5595 (MAPK3)
04062 Chemokine signaling pathway
5595 (MAPK3)
09152 Endocrine system
04910 Insulin signaling pathway
5595 (MAPK3)
04929 GnRH secretion
5595 (MAPK3)
04912 GnRH signaling pathway
5595 (MAPK3)
04915 Estrogen signaling pathway
5595 (MAPK3)
04914 Progesterone-mediated oocyte maturation
5595 (MAPK3)
04917 Prolactin signaling pathway
5595 (MAPK3)
04921 Oxytocin signaling pathway
5595 (MAPK3)
04926 Relaxin signaling pathway
5595 (MAPK3)
04935 Growth hormone synthesis, secretion and action
5595 (MAPK3)
04919 Thyroid hormone signaling pathway
5595 (MAPK3)
04928 Parathyroid hormone synthesis, secretion and action
5595 (MAPK3)
04916 Melanogenesis
5595 (MAPK3)
09153 Circulatory system
04261 Adrenergic signaling in cardiomyocytes
5595 (MAPK3)
04270 Vascular smooth muscle contraction
5595 (MAPK3)
09155 Excretory system
04960 Aldosterone-regulated sodium reabsorption
5595 (MAPK3)
09156 Nervous system
04724 Glutamatergic synapse
5595 (MAPK3)
04725 Cholinergic synapse
5595 (MAPK3)
04726 Serotonergic synapse
5595 (MAPK3)
04720 Long-term potentiation
5595 (MAPK3)
04730 Long-term depression
5595 (MAPK3)
04723 Retrograde endocannabinoid signaling
5595 (MAPK3)
04722 Neurotrophin signaling pathway
5595 (MAPK3)
09158 Development and regeneration
04360 Axon guidance
5595 (MAPK3)
04380 Osteoclast differentiation
5595 (MAPK3)
09159 Environmental adaptation
04713 Circadian entrainment
5595 (MAPK3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
5595 (MAPK3)
05206 MicroRNAs in cancer
5595 (MAPK3)
05205 Proteoglycans in cancer
5595 (MAPK3)
05207 Chemical carcinogenesis - receptor activation
5595 (MAPK3)
05208 Chemical carcinogenesis - reactive oxygen species
5595 (MAPK3)
05203 Viral carcinogenesis
5595 (MAPK3)
05230 Central carbon metabolism in cancer
5595 (MAPK3)
05231 Choline metabolism in cancer
5595 (MAPK3)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
5595 (MAPK3)
09162 Cancer: specific types
05210 Colorectal cancer
5595 (MAPK3)
05212 Pancreatic cancer
5595 (MAPK3)
05225 Hepatocellular carcinoma
5595 (MAPK3)
05226 Gastric cancer
5595 (MAPK3)
05214 Glioma
5595 (MAPK3)
05216 Thyroid cancer
5595 (MAPK3)
05221 Acute myeloid leukemia
5595 (MAPK3)
05220 Chronic myeloid leukemia
5595 (MAPK3)
05218 Melanoma
5595 (MAPK3)
05211 Renal cell carcinoma
5595 (MAPK3)
05219 Bladder cancer
5595 (MAPK3)
05215 Prostate cancer
5595 (MAPK3)
05213 Endometrial cancer
5595 (MAPK3)
05224 Breast cancer
5595 (MAPK3)
05223 Non-small cell lung cancer
5595 (MAPK3)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
5595 (MAPK3)
05170 Human immunodeficiency virus 1 infection
5595 (MAPK3)
05161 Hepatitis B
5595 (MAPK3)
05160 Hepatitis C
5595 (MAPK3)
05171 Coronavirus disease - COVID-19
5595 (MAPK3)
05164 Influenza A
5595 (MAPK3)
05163 Human cytomegalovirus infection
5595 (MAPK3)
05167 Kaposi sarcoma-associated herpesvirus infection
5595 (MAPK3)
05165 Human papillomavirus infection
5595 (MAPK3)
09171 Infectious disease: bacterial
05130 Pathogenic Escherichia coli infection
5595 (MAPK3)
05132 Salmonella infection
5595 (MAPK3)
05131 Shigellosis
5595 (MAPK3)
05135 Yersinia infection
5595 (MAPK3)
05133 Pertussis
5595 (MAPK3)
05152 Tuberculosis
5595 (MAPK3)
09174 Infectious disease: parasitic
05145 Toxoplasmosis
5595 (MAPK3)
05140 Leishmaniasis
5595 (MAPK3)
05142 Chagas disease
5595 (MAPK3)
09164 Neurodegenerative disease
05010 Alzheimer disease
5595 (MAPK3)
05020 Prion disease
5595 (MAPK3)
05022 Pathways of neurodegeneration - multiple diseases
5595 (MAPK3)
09165 Substance dependence
05034 Alcoholism
5595 (MAPK3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
5595 (MAPK3)
09167 Endocrine and metabolic disease
04930 Type II diabetes mellitus
5595 (MAPK3)
04933 AGE-RAGE signaling pathway in diabetic complications
5595 (MAPK3)
04934 Cushing syndrome
5595 (MAPK3)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
5595 (MAPK3)
01524 Platinum drug resistance
5595 (MAPK3)
01522 Endocrine resistance
5595 (MAPK3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:hsa01001]
5595 (MAPK3)
09182 Protein families: genetic information processing
03036 Chromosome and associated proteins [BR:hsa03036]
5595 (MAPK3)
09183 Protein families: signaling and cellular processes
04147 Exosome [BR:hsa04147]
5595 (MAPK3)
Enzymes [BR:hsa01000]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.11 Protein-serine/threonine kinases
2.7.11.24 mitogen-activated protein kinase
5595 (MAPK3)
Protein kinases [BR:hsa01001]
Serine/threonine kinases: CMGC group
MAPK family [OT]
5595 (MAPK3)
Chromosome and associated proteins [BR:hsa03036]
Eukaryotic type
Centromeric chromatin formation proteins
SAC (spindle assembly checkpoint) factors
Protein kinases
5595 (MAPK3)
Exosome [BR:hsa04147]
Exosomal proteins
Exosomal proteins of haemopoietic cells (B-cell, T-cell, DC-cell, reticulocyte, and mast cell)
5595 (MAPK3)
|
SSDB |
|
Motif |
|
Other DBs |
|
Structure |
|
LinkDB |
|
Position |
16:complement(30114105..30123220)
|
AA seq |
379 aa
MAAAAAQGGGGGEPRRTEGVGPGVPGEVEMVKGQPFDVGPRYTQLQYIGEGAYGMVSSAY
DHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYI
VQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDL
KICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS
NRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMKARNYLQSLPSKTKVAWAKLFPKSD
SKALDLLDRMLTFNPNKRITVEEALAHPYLEQYYDPTDEPVAEEPFTFAMELDDLPKERL
KELIFQETARFQPGVLEAP |
NT seq |
1140 nt +upstreamnt +downstreamnt
atggcggcggcggcggctcaggggggcgggggcggggagccccgtagaaccgagggggtc
ggcccgggggtcccgggggaggtggagatggtgaaggggcagccgttcgacgtgggcccg
cgctacacgcagttgcagtacatcggcgagggcgcgtacggcatggtcagctcggcctat
gaccacgtgcgcaagactcgcgtggccatcaagaagatcagccccttcgaacatcagacc
tactgccagcgcacgctccgggagatccagatcctgctgcgcttccgccatgagaatgtc
atcggcatccgagacattctgcgggcgtccaccctggaagccatgagagatgtctacatt
gtgcaggacctgatggagactgacctgtacaagttgctgaaaagccagcagctgagcaat
gaccatatctgctacttcctctaccagatcctgcggggcctcaagtacatccactccgcc
aacgtgctccaccgagatctaaagccctccaacctgctcatcaacaccacctgcgacctt
aagatttgtgatttcggcctggcccggattgccgatcctgagcatgaccacaccggcttc
ctgacggagtatgtggctacgcgctggtaccgggccccagagatcatgctgaactccaag
ggctataccaagtccatcgacatctggtctgtgggctgcattctggctgagatgctctct
aaccggcccatcttccctggcaagcactacctggatcagctcaaccacattctgggcatc
ctgggctccccatcccaggaggacctgaattgtatcatcaacatgaaggcccgaaactac
ctacagtctctgccctccaagaccaaggtggcttgggccaagcttttccccaagtcagac
tccaaagcccttgacctgctggaccggatgttaacctttaaccccaataaacggatcaca
gtggaggaagcgctggctcacccctacctggagcagtactatgacccgacggatgagcca
gtggccgaggagcccttcaccttcgccatggagctggatgacctacctaaggagcggctg
aaggagctcatcttccaggagacagcacgcttccagcccggagtgctggaggccccctag |